Literature DB >> 24250329

Steroid induced diabetes mellitus in patients receiving prednisolone for haematological disorders.

T R Kotila1, T Olutogun, A Ipadeola.   

Abstract

INTRODUCTION: Steroids are a useful component of combination chemotherapy or as a single agent in the treatment of haematological disorders even though there are adverse effects associated with its use.
METHODS: We report four patients who developed diabetes mellitus (DM) during treatment with steroids for haematological disorders despite a negative history of DM.
RESULTS: The mean age of the patients was 55 yrs and DM was diagnosed by fasting plasma glucose (FPG) after a cumulative steroid dose of 500-1800 mg.
CONCLUSION: It is necessary to have a baseline and frequent FPG in patients who are considered for combination chemotherapy which include steroid since the development of DM does not appear to be dose dependent or related to history of DM in the patient or family.

Entities:  

Keywords:  Adverse effect; Chemotherapy; Diabetes Mellitus; Haematological malignancy; Steroid

Mesh:

Substances:

Year:  2013        PMID: 24250329      PMCID: PMC3824423          DOI: 10.4314/ahs.v13i3.45

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  11 in total

1.  The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.

Authors:  H M RANNEY; A GELLHORN
Journal:  Am J Med       Date:  1957-03       Impact factor: 4.965

2.  A study of steroid-induced diabetes mellitus in leprosy.

Authors:  R Papang; A S John; S Abraham; P S S S Rao
Journal:  Indian J Lepr       Date:  2009 Jul-Sep

3.  Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease.

Authors:  Seo Yun Kim; Chul-Gyu Yoo; Chun Taeg Lee; Hee Soon Chung; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

4.  Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.

Authors:  O Odocha; J McCauley; V Scantlebury; R Shapiro; P Carroll; M Jordan; C Vivas; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

Review 5.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

6.  High-dose corticoid therapy in Hodgkin's disease and other lymphomas.

Authors:  T C Hall; O S Choi; A Abadi; M J Krant
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391

7.  Low-dose steroid maintenance for renal transplant recipients.

Authors:  H Kishikawa; K Nishimura; T Soda; K Yamanaka; T Hirai; M Kyo; M Takeda; M Fujisawa; Y Kokado; Y Ichikawa
Journal:  Transplant Proc       Date:  2010-12       Impact factor: 1.066

8.  Hyperglycemia induced by chemotherapeutic agents used in acute lymphoblastic leukemia: report of three cases.

Authors:  Y J Wang; H Y Chu; S G Shu; C S Chi
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1993-06

9.  [Transient diabetes mellitus related to L-asparaginase therapy].

Authors:  Crésio Alves; Carina Chaves; Mabel Souza
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-06

10.  Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function.

Authors:  Lorenzo G Gallon; Johan Winoto; Joseph R Leventhal; Michele A Parker; Dixon B Kaufman
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-06       Impact factor: 8.237

View more
  1 in total

1.  Non-communicable diseases are reaching epidemic proportions: evidence from low and middle income countries.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.